Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

ALK-Abello A/S

ALK B.CO ✓ COMPLIANT ☆ Track — members

Nasdaq Copenhagen · Healthcare · Pharmaceuticals ·

Denmark Mid Cap Analyst: BUY

Last Close

$33.84

▼ -0.64%

Market Cap $7.51B · Vol 201.16K

Key Metrics

P/E Ratio

37.71

FWD: 31.00

Market Cap

$7.51B

Mid Cap

Div Yield

0.73%

Annual dividend

EPS Growth

+19.13%

YoY

RSI (14)

41.21

Momentum

Beta

0.70

vs Market

52W High

$42.01

19.75% below

52W Low

$28.28

18.08% above

Volume

201.16K

Avg 127.33K

P/B

7.86

Price-to-book

ROE

20.88%

Return on equity

Free Float

65.48%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, ALK-Abello A/S (ALK B.CO) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does ALK B.CO pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-2.41%

-9.07%

-13.53%

+3.11%

YTD

-4.37%

+19.00%

+219.58%

+47.60%

Financials & Valuation

TTM · Annual

Total Revenue	$992.66M
Net Income	$188.25M
Revenue Growth (YoY)	+16.36%
Gross Margin	67.08%
Operating Margin	26.20%
Net Profit Margin	18.96%
ROE	20.88%
ROA · ROIC	18.90% · 18.09%

P/E Ratio	37.71
Forward P/E (FY1)	31.00
PEG Ratio	0.91
P/S	8.03
P/B	7.86
P/FCF	34.80
EPS Growth	+19.13%
Outstanding Shares	202.57M

Technical Indicators

50-Day SMA	$37.28
200-Day SMA	$35.38
RSI (14)	41.21
Beta	0.70
52-Week High	$42.01
52-Week Low	$28.28

Volume Today	201.16K
Avg Daily Volume (30D)	127.33K
Relative Volume	1.58x
Volatility (10D)	24.10
Volatility (30D)	18.92
Free Float	65.48%

Analyst Consensus

BUY

Current Price $33.84

Mean Target $43.86

52W Low$28.28 52W High$42.01

Current

Target

$28.28 $42.01

Current Analyst target

+29.61% upside potential · 5 analysts

Identifiers

ExchangeNasdaq Copenhagen

FIGIBBG001SNHVQ1

ISINDK0061802139

CountryDenmark

Sub-IndustryPharmaceuticals (NEC)

Earnings DateAug 20, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

ALK-Abello A/S is a Denmark-based company active within the pharmaceutical industry. It is engaged in the development and marketing of pharmaceutical products for the treatment, prevention and diagnosis of allergy. Its product portfolio comprises allergy vaccines, emergency treatments and allergy diagnostics products. The Company’s allergy vaccines product offering comprises tablet vaccines, sublingual vaccines and subcutaneous vaccines. Its emergency treatments product offering comprises products for the management of anaphylaxis. Its allergy diagnostics product offering comprises allergen extracts for allergy testing, such as skin-prick tests. The Company operates worldwide through subsidiaries, production units and distributors in such countries as Austria, Canada, France, Italy, the Netherlands, Poland, Spain, Switzerland, the United States and China.